Uveitis Gene-Expression Profiling



Status:Recruiting
Conditions:Cervical Cancer, Ocular
Therapuetic Areas:Oncology, Ophthalmology
Healthy:No
Age Range:21 - Any
Updated:5/3/2014
Start Date:June 2005

Use our guide to learn which trials are right for you!

Uveitis is a group of troublesome diseases that collectively represent a cause of blindness
comparable to diabetes. Most forms of uveitis are either infectious or immune-mediated. The
investigators propose to create a data base on peripheral blood gene expression for patients
with 3 of the most important diseases associated with uveitis: ankylosing spondylitis,
sarcoidosis, and Behcet's disease. The investigators will quantitatively measure the
expression of consistent alteration in peripheral blood from patients with more than 40,000
gene sequences using microarray gene chip technology. This approach is known to detect
systemic immune-mediated disease. The investigators will use this data base to:

1. Determine if patients with uveitis and ankylosing spondylitis, sarcoidosis, or Behcet's
can be distinguished from a normal population or controls with the same systemic
disease but no history of uveitis

2. Determine if the profile of gene expression can distinguish infectious or idiopathic
forms of uveitis from patients with spondylitis, sarcoidosis, or Behcet's

3. Determine how this gene profile changes over time as episodic disease such as
spondylitis or Behcet's activates or remits

4. Correlate the changes in gene expression with the prognosis of the ocular inflammatory
process.

The creation of a gene expression data base for patients with uveitis has the potential to
clarify the pathogenesis of disease, establish new diagnostic tools, and provide a means for
predicting prognosis.


Inclusion Criteria:

- The study group will include patients aged 21 years or older attending the Uveitis
Clinic at the Casey Eye Institute at OHSU who have uveitis of the following subtypes:

1. ankylosing spondylitis

2. sarcoidosis

3. Behçet's disease

4. toxoplasmosis

5. herpetic acute retinal necrosis; AND

6. idiopathic uveitis

- Another group of patients, also aged 21 years or more, with the following diseases
but no uveitis, will be recruited from the Rheumatology Clinic at OHSU as follows:

1. ankylosing spondylitis

2. sarcoidosis; AND

3. Behçet's disease

- The study group will also include 30 normal control volunteers aged 21 years or
older.

Exclusion Criteria:

- Special/vulnerable subject populations (e.g., mentally impaired persons and children)
will not be enrolled.
We found this trial at
1
site
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials